📷 Image: Wikimedia Commons / Archies2804
Health
Bhopal: New AIIMS Test Detects TB Drug Resistance
✍️ Amar Ujala · Bhopal
🗓 10 Aug 2026, 08:36 PM
👁 5
AIIMS Bhopal has developed a new test to identify drug resistance in MDR-TB patients. The test can detect effective drugs within 2 days.
In a significant breakthrough, AIIMS Bhopal has developed a new test to identify drug resistance in Multi-Drug Resistant Tuberculosis (MDR-TB) patients. This test can detect which drugs are effective against the disease within just 2 days. A study conducted on 74 patients revealed that around 19% of them had resistance to fluoroquinolones, a type of antibiotic. The new test is expected to revolutionize the treatment of MDR-TB in India.
The development of this test is a major milestone in the fight against TB, which is a significant public health concern in India. With this test, doctors can now quickly identify the most effective drugs for each patient, reducing the risk of further drug resistance and improving treatment outcomes.
The study's findings have significant implications for TB treatment in India, where the disease is a major health burden. The new test is likely to be a game-changer in the management of MDR-TB, enabling healthcare providers to provide more targeted and effective treatment to patients.
The development of this test is a major milestone in the fight against TB, which is a significant public health concern in India. With this test, doctors can now quickly identify the most effective drugs for each patient, reducing the risk of further drug resistance and improving treatment outcomes.
The study's findings have significant implications for TB treatment in India, where the disease is a major health burden. The new test is likely to be a game-changer in the management of MDR-TB, enabling healthcare providers to provide more targeted and effective treatment to patients.